Health
Ping An Asset Management No.36 in Top 500 Asset Managers 2023
HONG KONG and SHANGHAI, July 3, 2023 /PRNewswire/ -- Ping An Asset Management Co., Ltd. (PAAMC), a subsidiary of Ping An Insurance (Group) Company ofChina, Ltd. ("Ping An" or the "Group", HKEx:2318; SSE:601318) ranked 36th in the world in the Top 500 Asset Managers 2023 list from Investment & Pen...
2023-07-03 14:46
5208
Fair Play Menarini International Awards, the 2023 edition starts with the talk show "The Champions tell their Stories" in Piazza della Signoria, Florence
FLORENCE, Italy, July 3, 2023 /PRNewswire/ -- The countdown has begun to the XXVII edition of the Fair Play Menarini International Awards. Tomorrow, Monday, July 3rd, the 2023 edition of the event, dedicated to the sporting values of ethics, fair play and respect, will officially begin in the cit...
2023-07-03 09:31
2430
Innovent and IASO Bio Announce the NMPA Approval of FUCASO®, the First Fully-human BCMA CAR-T Therapy, for the Treatment of Relapsed or Refractory Multiple Myeloma
ROCKVILLE, Md. and SUZHOU, China, July 3, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...
2023-07-03 08:00
4320
Zymedi announced their collaboration with the National Heart, Lung, and Blood Institute through a CTA CRADA to develop ZMA001 mAb, a potential treatment for Pulmonary Arterial Hypertension (PAH), a rare, female predominant disease
SEOUL, South Korea, July 2, 2023 /PRNewswire/ -- Today Zymedi, a Korean biotech venture-backed company, announced the signing of a clinical Cooperative Research and Development Agreement (CRADA) with the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health ...
2023-07-03 08:00
2830
New Survey Reveals Insights on Singapore Workers' Preparedness for Digital Transformation
Study sheds light on perceptions, behaviours and changes towards digitalisation in the aftermath of the COVID-19 pandemic SINGAPORE, July 3, 2023 /PRNewswire/ -- Reeracoen, a leading provider of human resource services inSingapore, has released its latest report titled "Employee Attitudes Toward...
2023-07-03 07:45
2304
Lifera and CENTOGENE, Enter Strategic Collaboration - Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing
* Joint Venture (JV) combines CENTOGENE's global leadership in multiomics with local insight of Lifera, a biopharmaceutical company wholly owned by the Public Investment Fund (PIF) based inRiyadh. * JV focuses on providing state-of-the-art multiomic testing services to patients, health system...
2023-07-02 14:00
3283
Clinical Trial Data of Novel Metabolic Mechanism in Migraine: CER-0001, a Ketogenic Investigational Agent
* A poster showcasing data from the RELIEF study of CER-0001 (tricaprilin), being investigated for the preventive treatment of migraine, was presented at the 65th Annual Society Meeting of the American Headache Society * Data from the pilot study, showed a positive efficacy signal and supports...
2023-07-01 00:52
4145
Chime Biologics Announces Strategic Cooperation with Leads Biolabs and BeiGene to Advance LBL-007 mAb Development and Manufacturing Globally
* Leads Biolabs and Chime Biologics initiate strategic cooperation to accelerate IND application and provide clinical trial materials inChina. * BeiGene and Chime Biologics establish strategic cooperation to facilitate IND applications overseas and clinical trial materials supply. SHANGHAI, Ju...
2023-06-30 20:15
2651
Transcenta Presented PFS Data by CLDN18.2 Expression Level from Phase I/II Study of Osemitamab (TST001) plus CAPOX as the First-Line Treatment of Advanced G/GEJ Cancer at ESMO GI Annual Congress 2023
* 64 patients with CLDN18.2 positive G/GEJ cancer were enrolled in TranStar102 (TST001-1002). CLDN18.2 positivity is defined as ≥10% tumor cells with ≥1+ intensity. These patients represent approximately 55% of all G/GEJ adenocarcinomas. The overall median PFS was 9.5 months with no differences...
2023-06-30 17:33
2781
Bioheart (02185.HK) announces clinical result for Iberis-HTN at CIT 2023
SHANGHAI, June 30, 2023 /PRNewswire/ -- Bioheart (02185.HK), together with its holding subsidiary Angiocare announces the clinical result for Iberis-HTN at China Interventional Therapeutics 2023. Iberis-HTN is a prospective, multicenter, blinded, randomized controlled trial to evaluate the safety...
2023-06-30 11:37
2880
BGI Genomics obtains BSI ISO 37301 Compliance Management System Certification
HONG KONG, June 30, 2023 /PRNewswire/ -- As businesses become increasingly global, changes are happening at an extraordinary pace. Compliance is critical for large economies, industry regulations, and enterprise operations. BGI Genomics prioritizes compliance management and strictly follows law...
2023-06-30 08:37
3011
Leaked aspartame opinion misleading, more comprehensive review underway
WASHINGTON, June 30, 2023 /PRNewswire/ -- Reuters today (Thursday) published leaked reports that the World Health Organization's (WHO) sub-agency for cancer research (IARC) intends to classify the common low-calorie sweetener aspartame as "possibly carcinogenic," the same classification IARC appl...
2023-06-30 07:49
3108
Leaked aspartame opinion misleading, more comprehensive review underway
WASHINGTON, June 29, 2023 /PRNewswire/ -- Reuters today (Thursday) published leaked reports that the World Health Organization's (WHO) sub-agency for cancer research (IARC) intends to classify the common low-calorie sweetener aspartame as "possibly carcinogenic," the same classification IARC appl...
2023-06-30 02:02
2676
Harbour BioMed Announces Biologics License Application Acceptance of Batoclimab for Treatment of Generalized Myasthenia Gravis by NMPA
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, June 29, 2023 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunol...
2023-06-29 21:26
2438
IMG Partners with MAGNUS Search & Rescue to Offer Travel Medical Insurance
INDIANAPOLIS, June 29, 2023 /PRNewswire/ -- International Medical Group® (IMG® ), an award-winning global insurance benefits and assistance services company, has announced a new partnership with MAGNUS International Search & Rescue, a comprehensive emergency management and global on-ground search ...
2023-06-29 21:00
2425
Jowell Global Ltd. Granted Extension to Meet Nasdaq Minimum Bid Price Requirement
SHANGHAI, June 29, 2023 /PRNewswire/ -- Jowell Global Ltd. ("Jowell Global" or the "Company") (NASDAQ: JWEL), one of the leading cosmetics, health and nutritional supplements, and household products e-commerce platforms inChina, today announced that, onJune 27, 2023, the Company received a writte...
2023-06-29 20:00
3757
Angel Yeast Partners with PhaBuilder to Drive Wider Synthetic Biology Applications with Launch of Joint Venture PHA Factory
YICHANG, China, June 29, 2023 /PRNewswire/ -- Angel Yeast
2023-06-29 20:00
3270
Cresilon Receives First FDA Clearance For Human Use of Hemostatic Gel Technology
NEW YORK, June 29, 2023 /PRNewswire/ -- Cresilon, Inc. ("Cresilon"), a Brooklyn -based biotechnology company focused on hemostatic medical device technologies, today announced that it has been granted 510(k) clearance from the U.S. Food and Drug Administration ("FDA") for Cresilon Hemostatic Gel™ ...
2023-06-29 20:00
2117
HaemaLogiX Announces Positive Final Results from KappaMab Combination Phase IIb Myeloma Trial
* Significant improvement in Overall Response Rate (83%) compared with matched case control group (45%). * Significant overall survival advantage, with a 46% reduction in the risk of death. * Excellent safety profile and significant efficacy bolster HaemaLogiX's plan to progress further Kap...
2023-06-29 19:00
1800
CPHI & PMEC China 2023 to launch international roadshow in Guangzhou
China's booming Pearl River Delta, a key pharma manufacturing hub, sees rapid internationalisation SHANGHAI, June 29, 2023 /PRNewswire/ -- CPHI & PMEC China will open a special roadshow to be hosted at the PWTC Expo (4-6 September, 2023) in the city of Guangzhou (Guangdong Province). The new add...
2023-06-29 18:10
2258
Week's Top Stories
Most Reposted
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 313 media titles]
2024-11-12 09:00
DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
[Picked up by 294 media titles]
2024-11-13 09:00
Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 291 media titles]
2024-11-12 11:00
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00
Oxygen, HubSpot's leading solutions partner in Hong Kong & Greater China Expands to UAE
[Picked up by 285 media titles]
2024-11-15 15:25
Most Read
DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
2024-11-13 09:00
6529
Sobot Introduces its All-in-One Solution at GITEX Global 2024
2024-11-12 11:00
5924
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
2024-11-12 09:00
5699